ImmuneXcite (ImmuneXcite)

Oncology Corporate Profile

HQ Location

3 Forbes Road
Lexington, MA 2421

Company Description

ImmuneXcite is a privately held biotech company based in Lexington, Mass., that is developing the next generation of immune-activating biotherapeutics for cancer using a fundamentally novel innate and adaptive immunotherapy platform. The company's mAbXcite platform recruits neutrophils, the first responders of the immune system, to mount a natural, potent and precise attack on cancer cells. ImmuneXcite has two lead drug candidates, based on its mAbXcite platform, for cancers with high unmet medical needs.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
mAbXciteimmunotherapyVarious cancer typesPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display